Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial

Stern, EP; Host, LV; Wanjiku, I; Escott, KJ; Gilmour, PS; Ochiel, R; Unwin, R; Burns, A; Ong, VH; Cadiou, H; O'Keeffe, AG; Denton, CP

Denton, CP (通讯作者)，UCL Ctr Rheumatol & Connect Tissue Dis, 2nd Floor,UCL Med Sch Bldg,Royal Free Campus, London NW3 2PF, England.

ARTHRITIS RESEARCH & THERAPY, 2022; 24 (1):

Abstract

Background: We report results from a phase II randomised placebo-controlled trial assessing zibotentan, a highly selective endothelin receptor antagon......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索